Publication Topic

Jackson MA, Lea I, Rashid A, Peddada SD, Dunnick JK. 2006. Genetic alterations in cancer knowledge system: Analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci 90(2):400–418; doi: 10.1093/toxsci/kfj101.

Ebeler SE, Dingley KH, Ubick E, Abel S, Mitchell AE, Burns SA, et al. 2005. Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Exp Clin Res 31(1):19–27. PMID: 15921026.

Kester JE, Gentry P, Covington TR, Clewell HJ. Issues in the use of PBPK modeling in the development of cancer slope factors for perchloroethylene. Poster presented at the Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Warren DA, Kerger BD, Britt JK, James RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40(1):42-53; doi: 10.1016/j.yrtph.2004.04.005.

Goodman M, Teta MJ, Hessel PA, Garabrandt DH, Craven VA, Scrafford CG, Kelsh MA. 2004. Mesothelioma and lung cancer among motor vehicle mechanics: A meta-analysis. Ann Occup Hyg 48(4):309–326; doi: 10.1093/annhyg/meh022. PMID: 15148053.

Luippold RS, Mundt KA, Austin RP, Liebig EW, Panko JM, Crump C, Crump K, Proctor DM. 2003. Lung cancer mortality among chromate production workers. J Occup Environ Med 60(6):451–457; doi: 10.1136/oem.60.6.451.

Crump C, Crump K, Hack E, Luippold R, Mundt K, Liebig EW, Panko JM, Paustenbach DJ, Proctor DM. 2003. Dose-response and risk assessment of airborne hexavalent chromium and lung cancer mortality. Risk Anal 23(6):1147–1163; doi: 10.1111/j.0272-4332.2003.00388.x.

Dingley KH, Ubick EA, Chiarappa-Zucca ML, Nowell S, Abel S, Ebeler SE, et al. 2003. Effect of dietary constituents with chemopreventive potential on adduct formation of a low-dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutr Cancer 46(2):212–221; doi: 10.1207/S15327914NC4602_15. PMID: 14690798.

Martin EA, Gaskell M, Al-Azzawi F, Garner RC, Brown K, Boocock DJ, Mattock E, Pring DW, Dingley K, et al. 2003. Tamoxifen DNA damage detected in human endometrium using the ultra sensitive technique of accelerator mass spectrometry. Cancer Res 63(23):8461–8465. PMID: 14679010.

Mandel J, Kelsh MA. 2001. A review of the epidemiology of trichloroethylene and kidney cancer. Hum Ecol Risk Assess 7(4):727–735; doi: 10.1080/20018091094600.

Katona MA, Long TF, Kirman CR, Gargas ML, Rish WR. Derivation of a cancer potency factor and dermal absorption factor for benzo(a)pyrene. Toxicologist 54, Abstract 873. Presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.

Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. 2000. A pooled analysis of magnetic fields, wire codes and childhood leukemia. Epidemiol 227(2):294–306.

Stafford RS, Cyr PL. 1997. The impact of cancer on the physical function of the elderly and their utilization of health care. Cancer 80(10):1973-80; doi: 10.1002/(sici)1097-0142(19971115)80:10<1973::aid-cncr15>3.0.co;2-v.

Haws LC, Jackson BA, Turnbull D, Dressler WE. 1994. Two approaches for assessing human cancer risk from disperse blue 1. Regul Toxicol Pharmacol. 19(1):80-96; doi: 10.1006/rtph.1994.1007.

Sahl JD, Kelsh MA, Greenland S. 1993. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiol 4(2):104-114; doi: 10.1097/00001648-199303000-00005.